Peritoneal cancer treatment with cytoreductive surgery

Cytoreductive surgery for peritoneal cancer helps to remove as much tumor tissue as possible in the abdomen. The process begins with a thorough standard clinical evaluation of the patient to assess their overall health and determine their suitability for the procedure. Next, consultations with the medical team are arranged to discuss the treatment plan and address any concerns. Then, before the surgery, laboratory tests gather essential information about the patient's blood and urine parameters. Imaging tests are also carried out to provide details about cancer and its extent. Additional diagnostic tests may be done to determine the proper surgical approach. Cytoreductive surgery involves the removal of visible tumor tissue in the peritoneal cavity. The extent of the operation depends on the patient's case, the cancer size, and localization. Following the procedure, postoperative care is provided to ensure proper recovery. It includes pain management, monitoring for complications, and close follow-up with the medical team. Cytoreductive surgery for peritoneal cancer can be combined with other treatments like HIPEC chemo to enhance its effectiveness. These aim to improve outcomes and increase long-term disease control. The benefits include reducing the tumor burden and improving the patient's prognosis. In addition, it can help reduce symptoms and improve quality of life.